SCHEMBL22564561

SCHEMBL22564561

N#Cc1cc(-c2cc(-n3c4ccc(C(F)(F)F)cc4c4cc(C(F)(F)F)ccc43)c(-n3c4ccc(C(F)(F)F)cc4c4cc(C(F)(F)F)ccc43)cc2C#N)cc(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.39
RXRG P48443 1/20 0.39
XDH P47989 3/20 0.37
KIF11 P52732 1/20 0.36
CYP1A2 P05177 1/20 0.34
METAP2 P50579 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DGAT1 O75907 1/20 0.33
SOAT1 P35610 1/20 0.33
KCNH2 Q12809 1/20 0.33
MAT2A P31153 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CTSS P25774 1/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
PTPN1 P18031 1/20 0.31
PTPN6 P29350 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22564562 0.94 KIF11 (0.36) RXRARXRGXDHKIF11CYP1A2
SCHEMBL22822670 0.94 RXRA (0.37) RXRARXRGXDHKIF11CYP1A2
SCHEMBL19903507 0.94 TSHR (0.36) RXRARXRGXDHKIF11CYP1A2
SCHEMBL22564425 0.93 RXRA (0.39) RXRARXRGXDHKIF11CYP1A2
SCHEMBL22822659 0.91 RXRA (0.42) RXRARXRGXDHKIF11CYP1A2
SCHEMBL22822463 0.91 RXRA (0.42) RXRARXRGXDHKIF11CYP1A2
SCHEMBL22822145 0.91 RXRA (0.39) RXRARXRGXDHKIF11CYP1A2
SCHEMBL20617111 0.90 KIF11 (0.43) RXRARXRGXDHKIF11DGAT1
SCHEMBL20617048 0.90 RXRA (0.37) RXRARXRGXDHKIF11TSHR
SCHEMBL19917811 0.90 RXRA (0.41) RXRARXRGXDHKIF11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021473-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-06-01 US disclosed
US-20200399256-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-24 US disclosed
EP-3642302-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021473-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OCIAD2 RXRA 3552/4885RXRG 3138/4885XDH 430/4885
US-20200399256-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 RXRA 3876/4885RXRG 3543/4885XDH 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.